Biotech

All Articles

Praxis epilepsy medicine lessens confiscations in period 2 hearing

.Praxis Precision Medicines has actually racked up an additional midphase succeed in epilepsy this y...

Three officers surrender as Dyne blog posts mixed data for DMD candidate

.After leaving a clinical hold numerous years back, Dyne Therapeutics has shown brand-new stage 1/2 ...

Arrowhead fires off stage 3 records in rare metabolic ailment in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has presented its own give before a possible showdown along with Ionis, p...

Pfizer, Valneva show lyme ailment chance reliable for 2nd booster

.Pfizer and Valneva may have about two additional years to hang around before they produce the very ...

Fierce Biotech Managing Editor Ayla Ellison Talks Shop with Michelle Benz on the Future of Biotech.

.Allow's dive into a chat along with Ayla Ellison, Strong Biotech Managing Editor and also Michelle ...

New information show how Bayer's asundexian neglected to prevent movements

.Bayer put on hold the phase 3 trial for its own variable XIa inhibitor asundexian late in 2013 afte...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS tests

.Sanofi is still bented on taking its own a number of sclerosis (MS) med tolebrutinib to the FDA, ex...

Galapagos' stock up as fund reveals intent to mold its progression

.Galapagos is actually happening under extra tension from real estate investors. Having created a 9....

Cell- centered Sana scoops first CSO-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of considerable leadership hirings, shootings a...

Allist settles Jacobio $21M, landing duty in Mandarin KRAS race

.Shanghai Allist Pharmaceuticals has acquired on its own a starring job in China's KRAS market, payi...